Neuronetics STIM 深 沪
已收盘 05-08 16:00:00 美东时间
1.655
-0.185
-10.05%
华盛通- 最 高1.84
- 今 开1.84
- 成交量 298.88万股
- 最 低 1.64
- 昨 收 1.84
- 总市值 11.52万
- 52周最高 4.8495
- 市盈率 静 --
- 换手率 4294.97%
- 52周最低 0.80
- 委 比 -59.22%
- 总股本 6.96万
- 历史最高 39.39
- 量 比 0.93
- 振 幅 10.87%
- 历史最低 0.52
- 每 手 1
- 风险率 1.06%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Neuronetics shares are trading higher after the company reported better-than-expected Q1 financial results and reaffirmed its FY2026 sales guidance.
Neuronetics shares are trading higher after the company reported better-than-ex...
05-05 23:26
Full Transcript: Neuronetics Q1 2026 Earnings Call
Neuronetics (NASDAQ:STIM) held its first-quarter earnings conference call on Tu...
05-05 21:25
Neuronetics Affirms FY2026 Sales Guidance of $160.000M-$166.000M vs $162.467M Est
Business OutlookFor the second quarter of 2026, the Company expects total revenue growth in the mid-single digits.For the full year 2026, Neuronetics continues to expect:Total revenue between $160 million and $166
05-05 19:54
Neuronetics Q1 EPS $(0.16) Beats $(0.17) Estimate, Sales $34.454M Beat $34.183M Estimate
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.17) by 5.88 percent. This is a 23.81 percent increase over losses of $(0.21) per share from the
05-05 19:53
BRIEF-Neuronetics Q1 Gross Margin 46.9%
BRIEF-Neuronetics Q1 Gross Margin 46.9% May 05 (Reuters) - Neuronetics Q1 operating expenses USD 25.1 million. Q1 EPS USD -0.16
05-05 19:50
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Neuronetics Form4 Filing Shows Jorey Chernett Bought 200K Shares At An Average Price Of $1.54/Share
- SEC Filing
04-22 21:43
Neuronetics 10% owner Jorey Chernett buys USD 309,000 common shares
Neuronetics 10% owner Jorey Chernett buys USD 309,000 common shares Neuronetics 10% owner Jorey Chernett bought 200,000 common shares in open-market purchases at weighted-average prices of USD 1.58, USD 1.51. Chernett reported direct beneficial ownership of 9,978,988 Neuronetics shares following the
04-22 21:41
美股牛股 | SLNO飙涨32%，公司获高额溢价收购；AMC院线升12%
SLNO飙涨32%，公司获高额溢价收购；维珍银河大涨近25%，新型太空船本月开始地面测试叠加SpaceX上市预期利好；AMC院线升12%，复活节档期业绩创同期历史新高>>
04-07 19:03
Neuronetics Comments on Letter from Pointillist Family Office
Neuronetics, Inc. has responded to a public letter from Jorey Chernett at Pointillist Family Office, acknowledging the shareholder's engagement and agreeing that the company's current valuation does not reflect its business strength. The Board remains committed to maximizing shareholder value and is open to constructive dialogue. Neuronetics, a leader in neuroscience, offers NeuroStar Advanced Therapy, a non-invasive treatment for neurohealth con...
04-07 11:00
